Not logged in Differentiation into an Effector Memory Phenotype Potentiates HIV-1 Latency Reversal in CD4+ T Cells Kulpa, Deanna A.; Talla, Aarthi; Brehm, Jessica H.; Ribeiro, Susan Pereira; Yuan, Sally; Bebin-Blackwell, Anne-Gaelle; Miller, Michael; Barnard, Richard; Deeks, Steven G.; Hazuda, Daria; Chomont, Nicolas; Sekaly, Rafick-Pierre Share Save
Efficacy of GKT831 in patients with primary biliary cholangitis and inadequate response to ursodeoxycholic acid: Interim efficacy results of a phase 2 clinical trial Dalekos, George; Invernizzi, Pietro; Nevens, Frederik; Hans, Van Vlierberghe; Zigmond, Ehud; Andrade, Raul J.; Ben Ari, Ziv; Heneghan, Michael; Huang, Jonathan; Harrison, Stephen; Minuk, Gerald; Joern, Schattenberg; Moreno, Christophe; Vierling, John; Vincent, Catherine; Bowlus, Christopher; Lurie, Yoav; Muratori, Luigi; Niro, Grazia; Hirschfield, Gideon; Post, Anthony; Zeuzem, Stefan; Welzel, Tania; Ch'ng, Chin Lye; Levy, Cynthia; Miller, Michael; Albillos, Agustin; Collier, Jane D.; Corless, Lynsey; Dieterich, Douglas; Kremer, Andreas E.; Papatheodoridis, George; Romeo, David; Silveira, Marina; Bernstein, David; Cohen-Naftaly, Michal; Floreani, Annarosa; Borg, Brian; Carey, Elizabeth; Hollywood, Coral; Maliakkal, Benedict; Marzioni, Marco; Rabinovitz, Mordechai; Rupp, Christian; Sheridan, David; Stanca, Carmen; Swain, Mark G.; Veitsman, Ella; Dourakis, P. Spyridon; Wiese, Philippe Share Save
Share Save
Repeat testing of low-level HIV-1 RNA: assay performance and implementation in clinical trials White, Kirsten; Garner, Will; Wei, Lilian; Eron, Joseph J.; Zhong, Lijie; Miller, Michael D.; Martin, Hal; Plummer, Andrew; Tran-Muchowski, Cecilia; Lindstrom, Kim; Porter, James; Piontkowsky, David; Light, Angela; Reiske, Heinz; Quirk, Erin Share Save
Resistance analysis in patients with genotype 1-6 HCV infection treated with sofosbuvir/velpatasvir in the phase III studies Hezode, Christophe; Reau, Nancy; Svarovskaia, Evguenia S.; Doehle, Brian P.; Shanmugam, Ragavi; Dvory-Sobol, Hadas; Hedskog, Charlotte; McNally, John; Osinusi, Anu; Brainard, Diana M.; Miller, Michael D.; Mo, Hongmei; Roberts, Stuart K.; O'Leary, Jacqueline G.; Shafran, Stephen D.; Zeuzem, Stefan Share Save
Design and Synthesis of Piperazine Sulfonamide Cores Leading to Highly Potent HIV-1 Protease Inhibitors Bungard, Christopher J.; Williams, Peter D.; Schulz, Jurgen; Wiscount, Catherine M.; Holloway, M. Katharine; Loughran, H. Marie; Manikowski, Jesse J.; Su, Hua-Poo; Bennett, David J.; Chang, Lehua; Chu, Xin-Jie; Crespo, Alejandro; Dwyer, Michael P.; Keertikar, Kartik; Morriello, Gregori J.; Stamford, Andrew W.; Waddell, Sherman T.; Zhong, Bin; Hu, Bin; Jo, Tao; Diamond, Tracy L.; Bahnck-Teets, Carolyn; Carroll, Steven S.; Fay, John F.; Min, Xu; Morris, William; Ballard, Jeanine E.; Miller, Michael D.; McCauley, John A. Share Save
Global epidemiology of HCV subtypes and resistance-associated substitutions evaluated by sequencing-based subtype analyses Welzel, Tania M.; Bhardwaj, Neeru; Hedskog, Charlotte; Chodavarapu, Krishna; Camus, Gregory; McNally, John; Brainard, Diana; Miller, Michael D.; Mo, Hongmei; Svarovskaia, Evguenia; Jacobson, Ira; Zeuzem, Stefan; Agarwal, Kosh Share Save
NS5A resistance-associated substitutions in patients with genotype 1 hepatitis C virus: Prevalence and effect on treatment outcome Zeuzem, Stefan; Mizokami, Masashi; Pianko, Stephen; Mangia, Alessandra; Han, Kwang-Hyub; Martin, Ross; Svarovskaia, Evguenia; Dvory-Sobol, Hadas; Doehle, Brian; Hedskog, Charlotte; Yun, Chohee; Brainard, Diana M.; Knox, Steven; McHutchison, John G.; Miller, Michael D.; Mo, Hongmei; Chuang, Wan-Long; Jacobson, Ira; Dore, Gregory J.; Sulkowski, Mark Share Save
Post-treatment resistance analysis of hepatitis C virus from phase II and III clinical trials of ledipasvir/sofosbuvir Wyles, David; Dvory-Sobol, Hadas; Svarovskaia, Evguenia S.; Doehle, Brian P.; Martin, Ross; Afdhal, Nezam H.; Kowdley, Kris V.; Lawitz, Eric; Brainard, Diana M.; Miller, Michael D.; Mo, Hongmei; Gane, Edward J. Share Save
Share Save
Design and Synthesis of Novel, Selective GPR40 AgoPAMs Plummer, Christopher W.; Clements, Matthew J.; Chen, Helen; Rajagopalan, Murali; Josien, Hubert; Hagmann, William K.; Miller, Michael; Trujillo, Maria E.; Kirkland, Melissa; Kosinski, Daniel; Mane, Joel; Pachanski, Michele; Cheewatrakoolpong, Boonlert; Nolting, Andrew F.; Orr, Robert; Christensen, Melodie; Campeau, Louis-Charles; Wright, Michael J.; Bugianesi, Randal; Souza, Sarah; Zhang, Xiaoping; Di Salvo, Jerry; Weinglass, Adam B.; Tschirret-Guth, Richard; Nargund, Ravi; Howard, Andrew D.; Colletti, Steven L. Share Save
Share Save
Prevalence of Resistance-Associated Substitutions in HCV NS5A, NS5B, or NS3 and Outcomes of Treatment With Ledipasvir and Sofosbuvir Sarrazin, Christoph; Dvory-Sobol, Hadas; Svarovskaia, Evguenia S.; Doehle, Brian P.; Pang, Phillip S.; Chuang, Shu-Min; Ma, Julie; Ding, Xiao; Afdhal, Nezam H.; Kowdley, Kris V.; Gane, Edward J.; Lawitz, Eric; Brainard, Diana M.; McHutchison, John G.; Miller, Michael D.; Mo, Hongmei Share Save
Clinical Resistance to Velpatasvir (GS-5816), a Novel Pan-Genotypic Inhibitor of the Hepatitis C Virus NS5A Protein Lawitz, Eric J.; Dvory-Sobol, Hadas; Doehle, Brian P.; Worth, Angela S.; McNally, John; Brainard, Diana M.; Link, John O.; Miller, Michael D.; Mo, Hongmei Share Save
Share Save
Share Save
Share Save
RESISTANCE ANALYSES FOR LEDIPASVIR/SOFOSBUVIR CONTAINING REGIMENS IN PATIENTS INFECTED WITH CHRONIC HCVWHOHAVE ADVANCED LIVER DISEASE OR ARE POST LIVER TRANSPLANT (SOLAR-1 & 2 STUDIES) Charlton, M.; Manns, M.; Dvory-Sobol, H.; Svarovskaia, E.; Doehle, B.; Arterburn, S.; Yun, C.; Brainard, D. M.; Mchutchison, J. G.; Miller, M. D.; Mo, H.; Afdhal, N.; Mutimer, D. Share Save
RESISTANCE ANALYSIS OF GENOTYPE 1 OR 3 HCV-INFECTED PATIENTS TREATED WITH SOFOSBUVIR/VELPATASVIR+GS-9857 FOR 6 OR 8 WEEKS Gane, E.; Svarovskaia, E. S.; Dvory-Sobol, H.; Hyland, R. H.; Stamm, L. M.; Brainard, D. M.; Miller, M. D.; Mo, H.; Schwabe, C.; Stedman, C. A. Share Save
RESISTANCE ANALYSIS IN 1284 PATIENTS WITH GENOTYPE 1 TO 6 HCV INFECTION TREATED WITH SOFOSBUVIR/VELPATASVIR IN THE PHASE 3 ASTRAL-1, ASTRAL-2, ASTRAL-3 AND ASTRAL-4 STUDIES Hezode, C.; Reau, N.; Svarovskaia, E.; Doehle, B. P.; Chodavarapu, K.; Dvory-Sobol, H.; Mcnally, J.; Osinusi, A.; Brainard, D. M.; Miller, M. D.; Mo, H.; Roberts, S.; O'leary, J. G. Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
